Pulike Biological Engineering, Inc. (603566.SH) announced its performance forecast for the first half of 2024. According to preliminary calculations by the company's finance department, it is expected that the net income attributable to the parent company's shareholders in the first half of 2024 will be between 69 million yuan and 81 million yuan, a decrease of 34.77 million yuan to 46.77 million yuan compared to the same period last year, a year-on-year decrease of 30.03% to 40.40%.
It is expected that the net income attributable to the parent company's shareholders after deducting non-recurring gains and losses will be between 62 million yuan and 74 million yuan in the first half of 2024, a decrease of 49.32 million yuan to 61.32 million yuan compared to the same period last year, a year-on-year decrease of 40.00% to 49.73%.
Affected by factors such as the continued downturn in the downstream farming industry and intensified market competition, the company's operating performance in the first half of 2024 showed a decline compared to the same period last year. Through actively adjusting marketing strategies and strengthening cost control, the year-on-year decline in net income has been significantly narrowed in the second quarter.